The Topical Drugs Market size was valued at USD 195.77 billion in 2024, projected to reach USD 311.88 billion by 2032 with a CAGR of 6.02%. The U.S. market accounted for USD 62.26 billion in 2024. Major companies include Bayer, GSK, Novartis, Johnson & Johnson, and more. Dermal drug delivery holds the largest market share at 55%, with dry formulations leading at 60%. Hospitals and clinics are the largest end-use segment at 39%.

North America dominated the global topical drugs market in 2024, with Europe and Asia Pacific following suit. Astellas Pharma launched Skyrizi for plaque psoriasis, while Novartis introduced Xeljanz Cream for adult plaque psoriasis. The report includes sections on environmental compliance metrics, capacity utilization rates, supply chain disruption index, and technological adoption rate to help investors make informed decisions.

Read more at GlobeNewswire: Topical Drugs Market Size to Reach USD 311.88 Billion by